EDAP TMS S.A. ADR | Key People and Executives

Marc Oczachowski
Chief Executive Officer & Director
Philippe Chauveau
Chairman
Rob Michiels
Independent Director
Argil J. Wheelock
Independent Director
Pierre Beysson
Independent Director
Marc Oczachowski
Chief Executive Officer & Director
Francois Dietsch
Chief Financial Officer
Noah J. Bartsch
VP-Global Medical Regulatory & Quality Affairs
Blandine Confort
Investor Relations Officer
Philippe Chauveau
Chairman
Robert Michiels
Independent Director
Argil J. Wheelock
Independent Director
Pierre Beysson
Independent Director

About EDAP TMS

View Profile
Address
Parc d'Activités la Poudrette-Lamart
Vaulx-en-Velin Rhone-Alpes 69120
France
Employees -
Website http://www.edap-tms.com
Updated 07/08/2019
EDAP TMS SA develops, produces and markets minimally invasive medical devices for urological diseases. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is generally recommended for patients with localized prostate cancer who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment, Ablatherm-HIFU is approved and commercialized in Europe as a treatment for prostate cancer and is currently under regulatory review in the U.